What is the primary purpose of the Prescription Drug Marketing Act of 1987?

The primary purpose of the Prescription Drug Marketing Act of 1987 is to discourage the sale of counterfeit and misbranded drugs. This significant legislation was enacted in response to growing concerns about the safety and integrity of prescription medications. The Act established stricter regulations for the distribution and sale of prescription drugs, including the need for proper labeling and verification of source. It addressed issues such as the prescription drug supply chain, ensuring that medications distributed in the U.S. are safe and effective.

By implementing controls on the resale of prescription drugs and requiring state licensing for wholesale distributors, the Act aims to reduce the potential for counterfeit products entering the market. This focus on maintaining the integrity of the pharmaceutical supply chain is crucial in protecting public health and ensuring that patients receive safe and properly labeled medications.

Other options do not encapsulate the legislative intent as accurately. The promotion of generic drugs, offering funding for pharmacy education, and regulating prices pertain to different areas of pharmaceutical practice and public health policy but do not directly align with the core goals of the Prescription Drug Marketing Act.